World Market For Cancer Therapeutics And Biotherapeutics
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder.
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The report covers both currently marketed and late stage development cancer products. Revenues for each current market segment were generated using dollar and unit sales for each product.
The following approaches to cancer therapeutics are covered in the report:
1. Biotherapeutics
- Monoclonal Antibodies
- Interleukins/ Interferons
- Kinases and Other Treatments
2. Chemotherapy
- Alkylating Agents
- Antimetabolites
- Cytotoxic Agents
- Plant Derivatives
3. Hormone Therapy
- Corticosteroids
- Hormone Antagonists/ Antagonists
- Aromatase Inhibitors
- SERMS
The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development and/or have significant incidence/mortality rates are profiled. The market segments provide an overview, description of products on the market, list of products in late-stage development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.
A Primary Research Effort
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers' level.
Coverage of the Most Recent Product and Trends
The base year for data was 2008. Historical data was provided for the years 2004 through 2007, with forecast data provided for 2009 through 2013. Compound annual growth rates (CAGRs) are provided for the 2004-2008, 2009-2013 and 2004-2013 periods for each industry segment covered. Competitive analysis is provided for the year 2008. The forecasted market analysis for 2009-2013 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends. Some of the trends that affected this market include the following:
- Insurance and Reimbursement
- Drug Costs
- Personalized Medicine
- Alliances, Acquisitions and Licensing Agreements
- Alcohol's Affect on Cancer Incidence
- Healthy Lifestyles Continue to Show Promise for Cancer Prevention
- Marketing and Distribution Trends
- Geographical Trends
- Elderly Clinical Trial Involvement
- Late-Stage Drug Development Trends
Questions and Answers
Article Tags:
cancer therapeutics
,biotherapeutics
,chemotherapy
,hormone therapy
,market research reports
,market research
,market reports
,market size
,market analysis
This research report on Smart Grid Energy Technologies presents an in-depth analysis of the development, applications, products, manufacturers, and trends in the deployment of the Smart Grid in the United States and around the world.
Cancer translational research brings together scientists' and clinicians' suggestions to develop solutions to biomedical complications. This kind of applied research strives to offer strategies to questions surrounding the etiology, pathology, diagnosis, prevention and treating cancer.
Orbs are actually a lumpectomy or quadrantectomy combined with rotating the breast tissue or mobilize the flap into the cavity of the surgery time fill is removed. It also includes the comparative change in shape and size is doing in relation to breast and moved if necessary, does not affect the conversion of the breast. The deferred plan the reconstruction is not part of endoplasmic techniques. Both procedures are performed by specific thoracic surgeons.
What every woman fears for is losing her self confidence , losing hope and losing her personality. The term "Breast Cancer" is a very negative word and that it creates negative vibrations in her heart. So, to make her comfortable with the basics of breast cancer and to make her means any woman understand that this type of cancer is the least dangerous than all cancers and that if it is detected early then you will fight with it successfully. Causes, Symptoms, treatment, discussed in detail.
Mesothelioma is a rare cancer that originates in the mesothelium. The mesothelium is the protective lining that covers the body's internal organs. Mesothelioma occurs when the mesothelium cells start to divide uncontrollably.
Chemotherapy is a treatment for killing cancerous cells which is given intravenous or extra-venous to the cancer patient. Even breast cancer patients have to go through the treatment. This treatment mainly focuses on the cancerous cells that are spread in the blood stream in the whole body . If any cancerous cells are there then they are killed by the chemotherapy medicine. The medicine is very costly and it has to be taken for one or two days continuously for every 21 days .
Over the last 20 years, international sourcing activities have intensified as buyers have searched the world to find the best supply sources for their companies.
This report examines trends in EU imports and import prices for textiles and clothing as a whole and for 12 major product categories, namely cotton yarn, fabrics woven from synthetic staple fibres, fabrics woven from synthetic filament yarn, T-shirts, pullovers, trousers, women's blouses, men's shirts, women's overcoats, women's dresses, women's skirts, and women's suits.
UK Retail Futures 2014: Electricals provides comprehensive insight into sector related issues such as market shares, space expansion and the changing patterns of consumer demand. It combines this with a host of economic, social and political factors to derive thorough sector forecasts over the next five years.
Injectable bio-implants provide rapid non-surgical treatments and offer effective replacement, restoration, or modulation of function to lost, damaged, or dysregulated physiology. Market opportunities for injectable bio-implants are high in an increasingly aging population that demands fast, effective, and safe treatments for age-related conditions.
Due to rising affluence and increasing levels of health consciousness, growth in alcohol consumption has slowed in Western markets in recent years, while the sales of brands perceived as ‘premium quality' have risen.
Discuss this Article
